BNTXBioNTech SE
What is the market doing?
No clear lean: rangebound and insiders net selling (often routine).
Rangebound, no clear trend. Price is −1% vs its 200-day average.
Insiders were net sellers over the 90 days ending Oct 8, 2026; selling is often routine (taxes, diversification).
A token position, settled Sep 15, 2026, a few days of normal trading to cover. Up 0.9% since the previous count, down from 1.1% of shares outstanding three months ago.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How BNTX is trading
BioNTech SE is +0.76% over the past year while the S&P 500 is +18%: 18 points behind the market.
1-year return · S&P 500 +18%
- vs 200-day average
- −0.82%
vs 200-day average · below trend, but not far
- RSI (14)
- 48
RSI (14) · neutral
- Below its 52-week high
- 19%
Below its 52-week high
Details›
- Last close2026-10-09
- $96.95
- 1 monthS&P 500 +2.7%
- +0.60%
- 1 yearS&P 500 +18%
- +0.76%
- 5 yearsS&P 500 +88%
- −71%
- vs 50-day average$98.53
- −1.6%
- 52-week high
- $119.34
- 52-week low
- $83.89
- Annualised volatility
- 49%
| Year | Return |
|---|---|
| 2026 (year to date) | +1.8% |
| 2025 | −16% |
| 2024 | +8.0% |
| 2023 | −30% |
| 2022 | −41% |
| 2021 | +216% |
| 2020 | +141% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 7 | 3 of 7 | +1.4% |
| Feb | 7 | 1 of 7 | −3.8% |
| Mar | 7 | 4 of 7 | +5.8% |
| Apr | 7 | 3 of 7 | +7.7% |
| May | 7 | 4 of 7 | +2.9% |
| Jun | 7 | 4 of 7 | +3.5% |
| Jul | 7 | 7 of 7 | +13% |
| Aug | 7 | 4 of 7 | −3.0% |
| Sep | 7 | 2 of 7 | +1.3% |
| Oct | 7 | 4 of 7 | +1.8% |
| Nov | 7 | 6 of 7 | +19% |
| Dec | 7 | 2 of 7 | −3.3% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.